Boston Scientific Corp (BSX)
85.55
+0.83
(+0.98%)
USD |
NYSE |
Nov 05, 16:00
85.55
0.00 (0.00%)
After-Hours: 16:19
Boston Scientific Research and Development Expense (Annual): 1.414B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.414B |
| December 31, 2022 | 1.323B |
| December 31, 2021 | 1.204B |
| December 31, 2020 | 1.143B |
| December 31, 2019 | 1.174B |
| December 31, 2018 | 1.113B |
| December 31, 2017 | 997.00M |
| December 31, 2016 | 920.00M |
| December 31, 2015 | 876.00M |
| December 31, 2014 | 817.00M |
| December 31, 2013 | 861.00M |
| December 31, 2012 | 886.00M |
| December 31, 2011 | 895.00M |
| December 31, 2010 | 939.00M |
| December 31, 2009 | 1.035B |
| Date | Value |
|---|---|
| December 31, 2008 | 1.006B |
| December 31, 2007 | 1.091B |
| December 31, 2006 | 1.008B |
| December 31, 2005 | 680.00M |
| December 31, 2004 | 569.00M |
| December 31, 2003 | 452.00M |
| December 31, 2002 | 343.00M |
| December 31, 2001 | 275.00M |
| December 31, 2000 | 199.00M |
| December 31, 1999 | 197.00M |
| December 31, 1998 | 200.00M |
| December 31, 1997 | 167.00M |
| December 31, 1996 | 244.90M |
| December 31, 1995 | 173.70M |
| December 31, 1994 | 30.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.143B
Minimum
2020
1.414B
Maximum
2023
1.252B
Average
1.204B
Median
2021
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.741B |
| Baxter International Inc | 667.00M |
| Haemonetics Corp | 54.44M |
| ResMed Inc | 307.52M |
| Masimo Corp | 175.20M |